摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Chloro-6-(4-ethoxyphenoxy)pyrimidine | 607723-55-7

中文名称
——
中文别名
——
英文名称
4-Chloro-6-(4-ethoxyphenoxy)pyrimidine
英文别名
——
4-Chloro-6-(4-ethoxyphenoxy)pyrimidine化学式
CAS
607723-55-7
化学式
C12H11ClN2O2
mdl
MFCD13197800
分子量
250.68
InChiKey
NJHLADBVZKDSSF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    44.2
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • Thiazolidinedione and pharmaceutical composition comprising the same
    申请人:——
    公开号:US20040122031A1
    公开(公告)日:2004-06-24
    The present invention relates to a thiazolidinedione derivative, represented in formula (1) below, pharmaceutically acceptable salts thereof, and/or pharmaceutically acceptable solvates thereof. Further, the present invention provides a pharmaceutical composition comprising the compound represented in formula (1) below, 1 wherein: X represents a carbon or nitrogen atom, Y represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen, or an aryl group, Z represents an oxygen, nitrogen, or sulfur atom, and R 1 and R 2 each represent a hydrogen atom; or R 1 and R 2 together form a bond.
    本发明涉及一种噻唑烷二酮衍生物,其表示为下式(1),其药学上可接受的盐和/或药学上可接受的溶剂。此外,本发明提供了一种含有下式(1)所表示的化合物的制药组合物,其中:X表示碳或氮原子,Y表示氢原子,烷基,烷氧基,卤素或芳基,Z表示氧,氮或硫原子,R1和R2各自表示氢原子;或R1和R2结合形成键。
  • THIAZOLIDINEDIONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    申请人:Chong Kun Dang Pharmaceutical Corp.
    公开号:EP1490360A1
    公开(公告)日:2004-12-29
  • EP1490360A4
    申请人:——
    公开号:EP1490360A4
    公开(公告)日:2006-07-05
  • US6787551B2
    申请人:——
    公开号:US6787551B2
    公开(公告)日:2004-09-07
  • [EN] THIAZOLIDINEDIONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br/>[FR] DERIVES DE THIAZOLIDINEDIONE ET COMPOSITION PHARMACEUTIQUE LES CONTENANT
    申请人:CHONG KUN DANG PHARM CORP
    公开号:WO2003080605A1
    公开(公告)日:2003-10-02
    The present invention relates to a thiazolidinedione derivative, represented in formula (1) below, pharmaceutically acceptable salts thereof, and/or pharmaceutically acceptable solvates thereof. Further, the present invention provides a pharmaceutical composition comprising the compound represented in formula (1) wherein: X represents a carbon or nitrogen atom, Y represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen, or an aryl group, Z represents an oxygen, nitrogen, or sulfur atom, and R1 and R2 each represent a hydrogen atom; or R1 and R2 together form a bond.
查看更多